VANCOUVER, Sept. 4, 2018 - Cognetivity Neurosciences Ltd. (the "Company" or "Cognetivity") (CSE: CGN) (FWB: 1UB) is pleased to announce that it is now trading on the OTCQB in the United States of America. Cognetivity is now trading under the symbol CGNSF. The Company will also continue trading on the Canadian Securities Exchange ("CSE").
The Company's CEO and Director, Sina Habibi, commented, "As part of our strategy to continue to increase value for our shareholders we are very happy to announce that we have listed on the OTCQB market in the USA under the ticker symbol CGNSF. This is an important step in our public market strategy and will allow US investors an easier route to getting involved in the Cognetivity story. We have a growing exposure to the US market with our attendance at recent conferences and we will be taking the opportunity to grow our investor network in the largest capital markets going forwards. The USA forms an important part of our mission to help as many people as possible through our early diagnosis platform and we look forward to continuing to grow our presence there."
About Cognetivity Neurosciences Ltd.
Cognetivity is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA) for use in medical and commercial environments. Cognetivity's ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity aims to develop the ICA through planned clinical studies to the market in North America and Europe.
SOURCE Cognetivity Neurosciences Ltd